FDA Knocks Cell Phone-Brain Tumor Study
Posted on: Thursday, 6 April 2006, 21:00 CDT
WASHINGTON - Federal health officials on Thursday dismissed a recent study suggesting a link between long-term use of cellular and cordless telephones and brain tumors but said they will continue to monitor the safety of the wireless devices.
The study, a combined analysis of two studies published in 2003 and 2005, found an increased risk of malignant brain tumors associated with use of the phones over a decade or more in populations in Sweden.
The Food and Drug Administration said that finding was inconsistent with the conclusions reached by other studies and pointed out several shortcomings, including the design of the study, which was conducted by surveys distributed by mail, and the lack of supporting data from laboratory animals. That makes the conclusion "difficult to interpret," the FDA said on its Web site.
Scientists do not consider retrospective questionnaires the most accurate method of determining a link between behavior and disease.
The FDA added that it will continue to monitor studies looking at possible health effects resulting from exposure to radio frequency energy. It also plans a meeting "in the near future" to evaluate research on the issue and identify gaps that deserve further study.
---
On the Net:
FDA information on wireless phones: http://www.fda.gov/cdrh/wireless/
Source: Associated Press/AP Online
Related Articles
- FCC calls for study of wireless industry
- Neurocrine Announces Top-Line Results From 702 Study (Lilac PETAL Study) of Elagolix for Treatment of Endometriosis Pain
- CardioMEMS Announces Start of CHAMPION Pivotal Study of Wireless Pressure Sensing for Heart Failure Monitoring
- Miami Wireless Customers Make Most Calls, Verizon Wireless Study Finds
- Detroit Wireless Customers Love to Talk, Verizon Wireless Study Finds
- Memphis and Nashville, Tennessee, Wireless Customers Have the Gift of Gab, Verizon Wireless Study Finds
- FDA Requests Study for Neurocrine's Drug
- CORRECTING and REPLACING Reversal of Alzheimer's Cognitive Decline By New Treatment Suggested in Small Human Pilot Study; Peer Reviewed Study Published By Medscape General Medicine
- InSightec Announces Enrollment of African American Women in FDA PostMarketing Study
- FDA Halts Study on Dietary Supplements
 |
 |
User Comments (0)
RSS Feeds